SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Merck & Co., Inc.'s Vioxx Heart Risk Persists One Year After Stopping Use, University of Texas MD Anderson Cancer Center Study
October 14, 2008
 · 
1 min read
Drug Development
Drug May Reduce Coronary Artery Plaque, Sakakibara Heart Institute Of Okayama Study
October 13, 2008
 · 
1 min read
Drug Development
Statins May Prevent Miscarriages, Hospital for Special Surgery Study Suggests
October 13, 2008
 · 
1 min read
Drug Development
Tamoxifen Cuts Fracture Risk, CancerCare Manitoba Study
October 13, 2008
 · 
1 min read
Drug Development
Novartis AG Booster Jab May Protect Against Avian Flu In A Week, University Hospitals Leicester Study
October 10, 2008
 · 
1 min read
Drug Development
Drug Sorafenib Improves Kidney Cancer Outcomes, Addenbrooke’s Hospital And University of Cambridge Study
October 10, 2008
 · 
1 min read
Drug Development
Some Arteries Opened Safely Without Heparin, University of Turin Study
October 10, 2008
 · 
1 min read
Drug Development
Belt And Braces Approach May Prevent Deep Vein Thromboses, Cochrane Researchers Find
October 9, 2008
 · 
1 min read
Drug Development
Do Prostate Drugs Harm Bones? Study: 1 Class Of Drugs (Includes Merck & Co., Inc. Proscar) For Enlarged Prostate Does Not Increase Risk Of Hip Fractures, Kaiser Permanente Study
October 8, 2008
 · 
1 min read
Drug Development
FDA: New Data Show No Stroke Risk With Pfizer Inc. (JOBS) Inhaler
October 8, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Sanofi Pasteur Touts Positive Trial Data For Fluzone High-Dose Vaccine
August 14, 2014
 · 
13 min read
Drug Development
Pfizer Inc. Reports Top-Line Results From Two Placebo-Controlled Studies With Lyrica
August 13, 2014
 · 
7 min read
Drug Development
Ampio Pharmaceuticals, Inc. Updates On Positive One-Month Results From Ampion Open Label Study
August 5, 2014
 · 
3 min read
Drug Development
Berlin Heart, Inc. Completes Enrollment In The EXCOR® Pediatric Ventricular Assist Device (VAD) Post Approval Study
August 4, 2014
 · 
2 min read
Drug Development
Hemispherx Biopharma’s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses
August 4, 2014
 · 
6 min read
Drug Development
Alexion Pharmaceuticals Inc. Release: European Commission Grants Orphan Drug Designation To Soliris® (Eculizumab) For The Treatment Of Patients With Myasthenia Gravis (MG)
August 1, 2014
 · 
1 min read
Drug Development
Study Claims Celgene Drug Can Drive HIV Out Of Hiding
July 24, 2014
 · 
1 min read
Drug Development
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands
July 21, 2014
 · 
8 min read
Drug Development
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study
July 18, 2014
 · 
14 min read
Drug Development
Bristol-Myers Squibb Company And Pfizer Inc. Announce Enrollment Of First Patient In Phase IV EMANATE Trial To Assess Effectiveness And Safety Of Eliquis® (Apixaban) In Patients With NVAF Undergoing Cardioversion
July 17, 2014
 · 
13 min read
Drug Development
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Candidiasis
July 16, 2014
 · 
2 min read
Drug Development
ACell, Inc. Initiates Post-Market Study Of MatriStem® Pelvic Floor Matrix
July 15, 2014
 · 
4 min read
Drug Development
Celgene’s OTEZLA® Misses Mark In Phase 3 Spinal Arthritis Study
July 9, 2014
 · 
8 min read
Drug Development
Merck & Co., Inc.'s Gardasil HPV Vaccine Doesn’t Increase Blood Clot Risk
July 9, 2014
 · 
1 min read
Drug Development
Sunovion Pharmaceuticals Inc. Announces Data Published In The CHEST Journal From A One-Year, Large Simple Safety Study Evaluating BROVANA® (Arformoterol Tartrate) Inhalation Solution
July 8, 2014
 · 
1 min read
Drug Development
Merck & Co., Inc.'s Januvia Linked To Increase In Heart Failure Hospitalizations
July 7, 2014
 · 
1 min read
Drug Development
Roche Finds “Serious Flaws” In Recent Study Doubting Tamiflu’s Effectiveness
July 1, 2014
 · 
1 min read
Drug Development
FDA Grants Breakthrough Therapy Designation To Pradaxa® (Dabigatran Etexilate) Specific Investigational Antidote
June 30, 2014
 · 
1 min read
Drug Development
Veloxis Pharmaceuticals A/S Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)
June 30, 2014
 · 
1 min read
Drug Development
InDex Pharmaceuticals AB Announces Results From COLLECT, A Clinical Trial Of Kappaproct® In The Treatment Of Moderate To Severe Ulcerative Colitis
June 27, 2014
 · 
3 min read
Load More